| __timestamp | Evotec SE | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 12404000 | 855506000 |
| Thursday, January 1, 2015 | 18343000 | 996170000 |
| Friday, January 1, 2016 | 18108000 | 1047690000 |
| Sunday, January 1, 2017 | 17614000 | 1324625000 |
| Monday, January 1, 2018 | 35619000 | 1416476000 |
| Tuesday, January 1, 2019 | 58432000 | 1754540000 |
| Wednesday, January 1, 2020 | 63945000 | 1829537000 |
| Friday, January 1, 2021 | 72200000 | 3051100000 |
| Saturday, January 1, 2022 | 76642000 | 2540300000 |
| Sunday, January 1, 2023 | 57519000 | 3162900000 |
| Monday, January 1, 2024 | 3630300000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Vertex Pharmaceuticals Incorporated has consistently outpaced Evotec SE in R&D investment. From 2014 to 2023, Vertex's R&D expenses surged by approximately 270%, peaking at over $3.16 billion in 2023. In contrast, Evotec's R&D spending grew by about 364%, reaching nearly $76.6 million in 2022, before a slight dip in 2023.
This stark difference highlights Vertex's aggressive strategy in pioneering new treatments, particularly in areas like cystic fibrosis. Meanwhile, Evotec's steady growth reflects its focus on collaborative drug discovery. As the pharmaceutical industry evolves, these spending patterns underscore the strategic priorities of each company, with Vertex leading the charge in high-stakes innovation.
Who Prioritizes Innovation? R&D Spending Compared for Novartis AG and Vertex Pharmaceuticals Incorporated
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated or Neurocrine Biosciences, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Genmab A/S
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Axsome Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and MannKind Corporation
Comparing Innovation Spending: Vertex Pharmaceuticals Incorporated and Taro Pharmaceutical Industries Ltd.
Research and Development Expenses Breakdown: Corcept Therapeutics Incorporated vs Evotec SE
Ionis Pharmaceuticals, Inc. vs Evotec SE: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Apellis Pharmaceuticals, Inc. and Evotec SE
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Evotec SE
R&D Spending Showdown: Geron Corporation vs Evotec SE